Vendetti et al., (2018) showed that the ATR kinase inhibitor AZD6738 attenuated radiation-induced CD8+ T cell depletion and enhanced CD8+ T cell activity in mouse models of Kras-mutated cancer in combination with conformal radiotherapy. This evidence concerns the gene CD8A and cancer.